A team of horticulturists, bio-breeders and agriculture specialists affiliated with a host of institutions across China has ...

Gene mutations have consequences both good and bad—from resistance to conditions like diabetes to susceptibility to certain ...

By exploiting the genetic variation in cancer cells, an already approved cancer drug demonstrated enhanced effects against ...

Today, Invizyne Technologies, Inc., (NASDAQ:IZTC) ("Invizyne"), a leading designer of cell-free, enzyme-based ...

The research also highlights potential avenues for repurposing existing drugs. Researchers found that trimethoprim and ...

enzyme-linked immunosorbent assay (ELISA) solutions, and Western blot tests worldwide. Founded in 1993 by histologist Steven ...

During the conference, Mr. Sapirstein will be available to conduct one-on-one meetings with registered investors, showcasing ...

Today, Invizyne Technologies, Inc., (NASDAQ:IZTC) ("Invizyne"), a leading designer of cell-free, enzyme-based ...

"The plant enzyme that's key to artepillin C production had only recently ... In the journal ACS Synthetic Biology, they now ...

The researchers used a systems biology approach, combining genetic studies, RNA sequencing and metabolic modeling. They found ...